The absorbance of citrullinated PAD4 was significantly higher in SF from patients with RA than OA (0.168 ± 0.078 and 0.046 ± 0.035, respectively; P = 0.0009; Fig. 4a). The gene discussed is PADI4; the disease is rheumatoid arthritis.